课题基金 / 基金详情

Analysis of mechanism for VEGF expression in renal cell carcinoma

Analysis of mechanism for VEGF expression in renal cell carcinoma
肾细胞癌中VEGF表达的机制分析
批准号:
08671852
负责人:
MIZOKAMI Atsushi
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

MIZOKAMI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I carried out northem blot analysis for VEGF mRNA in several renal cell carcinoma cell lines which I have. SN12C cells expressed VEGF mRNA most in four cell lines. Furthermore, 20 ng/ml TPA induced VEGF mRNA by 4 times of control. Actinomycin D treatment indicated that TPA regulated VEGF mRNA under the transcriptional level. Next, I amplified the 2.3 kb VEGF promoter region by PCR,subcloned into luciferase reporter plasmid. It was confirmed that this reporter has strong luciferase activity after transfected into SN12C cells, suggesting that this promoter has enough promoter activity for experiments. 20 ng/ml TPA induced this promoter activity by 5 times. Furthermore, TPA could induce promoter activity by 10 times even minimal VEGF promoter (59 bp promoter that included one GC box) was employed, indicating that TPA act on a basal transcriptional initiation complex and regulates VEGF mRNA expression. I also investigated important cis-acting elements that regulate VEGF expression. I constructed a serial deletion mutants of VEGF promoter region, transfected SN12C with these reporters, and compared luciferase activities. First, cis-acting elements were detected between 59 bp and 86 bp upstream of the transcription initiation site (TIS). Since this region included three GC boxes, these GC box was seemed to play an important role in basal transcription. Second, another cis-acting element was identified between 131 bp and 400 bp of TIS.Now I am subcloning this promoter region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The development of the innovative therapeutic drugs which targete crosstalk in the prostate cancer microenvironment
  • 批准号:
    17H04325
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2017
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Prevention of CRPC and application for docetaxel treatment using flavonoids
  • 批准号:
    25462472
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2013
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Identification of androgen-response genes related with the proliferation and development of proliferation-related marker in prostate cancer
  • 批准号:
    21592037
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Identification of progression-related genes in prostate cancer and application to treatment
  • 批准号:
    17591669
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2005
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
国内基金
海外基金
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
  • 批准号:
    JCZRLH202601503
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
  • 批准号:
    2026JJ80680
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    姜平
  • 依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
  • 批准号:
    2026JJ80684
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    龚攀
  • 依托单位: